At BRIJ Medical, our flagship product is the Brijjit® Force Modulating Tissue Bridge, a next-level innovation for incision closure, wound support and scar therapy.- Clinical Proven Benefits: (validated in multiple studies, including a randomized clinical trial)* Reduces wound breakdown by 90%* Decreases scar area by 38%- Eliminates Tension: Actively reduces up to 100% of tension on incisions and healing wounds.- Time-Saving: Allows for closure up to 9x faster than sutures (as fast as staples).- Cost-Effective: Can replace final layer closure and be used in private practice, ASCs, and hospitals.At BRIJ Medical, we provide enhanced control and confidence at every step of the healing journey. For more information, visit BRIJmedical.com.

+ Managing and executing development of new wound closure and scar therapy products that leverage mechanomodulation to relieve tension across the wound.

+ Responsible for building and leading a team of PhD/MS scientists to develop neuromodulation products from bench to bedside to treat chronic and acute pain.+ R&D lead for a complex cross-functional program developing an opioid-free platform technology for acute pain management.

Responsible for leading early stage technology development projects and in screening external technology and med device partnership opportunities submitted to the company for evaluation.+ Leading cross-functional project team to assess technical feasibility and reduce risk associated with new concepts in the area of chronic and acute pain management.+ Managing Halyard Innovation Portal, which includes working with business teams from across the organization to assess partnership opportunities and serve as point person for initial engagement with external inventors.

Responsible for working with senior business leaders to identify long-term product strategies, translating these into an actionable technology development plan, and then executing on this plan by leading both internal and external technology teams.+ Led technical team to identify key technical improvements to cyanoacrylate chemistry of InteguSEAL microbial sealant and developed 5-year product and technology roadmap in this area. Developed several of these cyanoacrylate technologies and prototyped a non-cyanoacrylate film-forming polymer chemistry that can immobilize bacteria with equivalent performance and improved ease of use. (EP 2,046,294; EP 2,061,524; EP 2,066,361; EP 2,200,690; US 2011/0152925)+ Led external technical teams at three separate companies to develop extruded polyurethane thin films with improved water vapor barrier. This included evaluation of coating technologies, polymer additives, new polyurethane resins, and alternatives to polyurethane. Work led to three feasible approaches which improved water vapor barrier by >20%.+ Key technical liaison between Health Care sector and Corporate R&D. Responsible for development and refresh of sector technology roadmap and providing guidance on portfolio management and project milestones relating to medical devices. Led internal technology development efforts to identify and conduct initial feasibility testing in areas of digestive health and respiratory care.+ Developed technology scouting capability within Health Care sector to identify external partners with needed technical capability and intellectual property to enable long-term product visions and enhance concept development process. Designed and implemented an external innovation portal and review process to allow people outside the company to submit their medical device inventions to Kimberly-Clark.

Provided leadership of technology development efforts on regulated medical devices.+ Led project team to develop novel vacuum packaging and radiation sterilization process for nonwoven surgical gowns and drapes. Development efforts included screening of radiation stabilizer melt additives, understanding method of polymer degradation, and optimizing packaging materials and processes required to meet product specifications. Technology was shared with and commercialized by KC Professional sector in adjacent space of clean room garments. (US 8,323,562)+ Technical lead on large cross-functional team responsible for development of infection control apparel products with antimicrobial treatments designed to reduce the incidence of hospital acquired infections. Successfully balanced conflicting properties of fluid barrier, static decay, and antimicrobial efficacy in final treatment formulation. Provided detailed cost model on treatment costs and developed kill curves for microbes of interest. (US 7,845,351, EP 1,943,302, EP 1,919,996)+ Led technical team to identify key technology areas in Health Care sector that would drive business over 3, 5 and 10 year time horizons and then worked with Chief Strategy Officer to prioritize technology areas across all business sectors as part of corporate technology strategy effort.

Led team of scientists to develop advanced nonwoven materials in areas of business need.+ Team demonstrated feasibility of nanofiber spinning and flexographic printing of Kraton elastomers on necked spunbond to improve the elastic modulus and reduce hysteresis while maintaining fluid intake and breathability of composite materials used in personal care products to enable all-over stretch. (US 2005/067843)+ Team developed self-warming nonwoven materials that are capable of maintaining 40 C for 4-6 hours in a very controlled fashion to provide therapeutic heating for medical or home uses. The heating action in the nonwoven is created through an oxidative chemical reaction that initiates upon opening of the packaging. (US 7,338,516; US 7,763,061)

Individual contributor on development and commercialization teams responsible for treatment chemistries and technologies used to modify the surface properties of nonwoven roll goods.+ Developed and commercialized internal melt additive for MicroCOOL breathable barrier film used in surgical apparel. Responsibilities included design of experiments to identify best additive chemistry and optimal addition level, coordination of testing to obtain product and occupational safety approvals, and development of bench test to correlate surface energy to viral barrier properties. (US 7,381,666)+ Developed new topical treatment formulation for application of fluorochemicals to barrier nonwovens that greatly enhances fluid barrier and lowers the cost of the treatment step. Improvements were obtained by understanding electrostatic interactions between fluoropolymer chains and adding an agent to screen these interactions while removing surface active agents that tend to depress the fluid barrier properties. (US 7,811,949; US 7,931,944)+ Developed new methods to reduce blood strikethrough on cuffs of surgical gowns through chemical treatments of the cuff, converting methods, and disrupting fluid channels to prevent wicking of blood. (US 6,934,969; US 7,155,746)+ Developed printing process that enables high speed, registered, crock-fast graphics to be applied to nonwovens roll goods moving at extremely high speeds (up to 1000 fpm). Solution required improvements to ink/polyolefin interface to improve ink adhesion, tracking technologies to ensure proper placement of individual colors to form desired multi-color graphic, and air handling systems to minimize impact of air disturbances on print quality. (US 6,957,884)

+ Anionically synthesized block copolymers and devised new experiments for imaging and understanding the physics of tethered polymer chains. Developed collaborations with scientists in France, Germany, and various US universities to enhance the impact of thesis work through computational modeling and novel synthesis techniques.

+ Worked in the production and lab assay of biological buffers. + Production work included operation of ion-exchange columns, reaction vessel, centrifuge, rotary and shelf dryers, lyopholyzer, and particle blender.